A real world study to assess the risk and severity of Gastrointestinal bleeding in patients under direct oral anticoagulant therapy
Latest Information Update: 19 Feb 2020
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Adverse reactions
Most Recent Events
- 19 Feb 2020 New trial record